AU566974B2

AU566974B2 – Pharmaceutical preparations containing a phospholipidan an oxicam derivative
– Google Patents

AU566974B2 – Pharmaceutical preparations containing a phospholipidan an oxicam derivative
– Google Patents
Pharmaceutical preparations containing a phospholipidan an oxicam derivative

Info

Publication number
AU566974B2

AU566974B2
AU36685/84A
AU3668584A
AU566974B2
AU 566974 B2
AU566974 B2
AU 566974B2
AU 36685/84 A
AU36685/84 A
AU 36685/84A
AU 3668584 A
AU3668584 A
AU 3668584A
AU 566974 B2
AU566974 B2
AU 566974B2
Authority
AU
Australia
Prior art keywords
phospholipidan
pharmaceutical preparations
preparations containing
oxicam derivative
oxicam
Prior art date
1983-12-22
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)

Ceased

Application number
AU36685/84A
Other versions

AU3668584A
(en

Inventor
Manfred Durr
Miklos Ghyczy
Jorg Hager
Sigurd Leyck
Armin Wendel
Helmut Wetzig
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

A Natterman und Cie GmbH

Original Assignee
A Natterman und Cie GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
1983-12-22
Filing date
1984-12-14
Publication date
1987-11-05

1984-12-14
Application filed by A Natterman und Cie GmbH
filed
Critical
A Natterman und Cie GmbH

1985-06-27
Publication of AU3668584A
publication
Critical
patent/AU3668584A/en

1987-11-05
Application granted
granted
Critical

1987-11-05
Publication of AU566974B2
publication
Critical
patent/AU566974B2/en

2004-12-14
Anticipated expiration
legal-status
Critical

Status
Ceased
legal-status
Critical
Current

Links

Espacenet

Global Dossier

Discuss

Classifications

A—HUMAN NECESSITIES

A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE

A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES

A61K31/00—Medicinal preparations containing organic active ingredients

A—HUMAN NECESSITIES

A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE

A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES

A61K31/00—Medicinal preparations containing organic active ingredients

A61K31/66—Phosphorus compounds

A61K31/683—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols

A61K31/685—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols one of the hydroxy compounds having nitrogen atoms, e.g. phosphatidylserine, lecithin

A—HUMAN NECESSITIES

A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE

A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES

A61K33/00—Medicinal preparations containing inorganic active ingredients

A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay

A—HUMAN NECESSITIES

A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE

A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES

A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient

A61K47/02—Inorganic compounds

A—HUMAN NECESSITIES

A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE

A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES

A61K9/00—Medicinal preparations characterised by special physical form

A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate

A61K9/4808—Preparations in capsules, e.g. of gelatin, of chocolate characterised by the form of the capsule or the structure of the filling; Capsules containing small tablets; Capsules with outer layer for immediate drug release

A—HUMAN NECESSITIES

A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE

A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS

A61P1/00—Drugs for disorders of the alimentary tract or the digestive system

A—HUMAN NECESSITIES

A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE

A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS

A61P1/00—Drugs for disorders of the alimentary tract or the digestive system

A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants

A—HUMAN NECESSITIES

A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE

A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS

A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

C—CHEMISTRY; METALLURGY

C07—ORGANIC CHEMISTRY

C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM

C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic System

C07F9/02—Phosphorus compounds

C07F9/06—Phosphorus compounds without P—C bonds

C07F9/08—Esters of oxyacids of phosphorus

C07F9/09—Esters of phosphoric acids

C07F9/10—Phosphatides, e.g. lecithin

Abstract

Pharmaceutical preparation containing phospholipids for the therapeutic treatment of rheumatic diseases which contain in addition to the antiphlogistically acting oxicam derivatives of the general formula special 1,2-diacyl-glycero-3-phosphocholines wherein 75-86% by weight of the acyl radicals are unsaturated fatty acid radicals, and the preparation thereof.

AU36685/84A
1983-12-22
1984-12-14
Pharmaceutical preparations containing a phospholipidan an oxicam derivative

Ceased

AU566974B2
(en)

Applications Claiming Priority (2)

Application Number
Priority Date
Filing Date
Title

DE3346526A

DE3346526C2
(en)

1983-12-22
1983-12-22

Pharmaceutical preparation for the therapeutic treatment of rheumatic diseases

DE3346526

1983-12-22

Publications (2)

Publication Number
Publication Date

AU3668584A

AU3668584A
(en)

1985-06-27

AU566974B2
true

AU566974B2
(en)

1987-11-05

Family
ID=6217768
Family Applications (1)

Application Number
Title
Priority Date
Filing Date

AU36685/84A
Ceased

AU566974B2
(en)

1983-12-22
1984-12-14
Pharmaceutical preparations containing a phospholipidan an oxicam derivative

Country Status (24)

Country
Link

US
(1)

US4687766A
(en)

EP
(1)

EP0147735B1
(en)

JP
(1)

JPS60169420A
(en)

KR
(1)

KR920003602B1
(en)

AT
(1)

ATE40793T1
(en)

AU
(1)

AU566974B2
(en)

CA
(1)

CA1234049A
(en)

DD
(1)

DD233076A5
(en)

DE
(2)

DE3346526C2
(en)

DK
(1)

DK619484A
(en)

EG
(1)

EG17137A
(en)

ES
(1)

ES8707111A1
(en)

FI
(1)

FI83287C
(en)

GR
(1)

GR82545B
(en)

HU
(1)

HU193729B
(en)

IL
(1)

IL73849A
(en)

IN
(1)

IN162327B
(en)

MX
(1)

MX159874A
(en)

NO
(1)

NO166569C
(en)

NZ
(1)

NZ210648A
(en)

OA
(1)

OA07907A
(en)

PH
(1)

PH21823A
(en)

PT
(1)

PT79649B
(en)

ZA
(1)

ZA849976B
(en)

Families Citing this family (10)

* Cited by examiner, † Cited by third party

Publication number
Priority date
Publication date
Assignee
Title

US5154930A
(en)

*

1987-03-05
1992-10-13
The Liposome Company, Inc.
Pharmacological agent-lipid solution preparation

US5376381A
(en)

*

1988-02-25
1994-12-27
The Liposome Company, Inc.
Integrity protected gelatin

GB9212450D0
(en)

*

1992-06-11
1992-07-22
Indena Spa
New derivatives of non-steroidal anti-inflammatory,analgesic and/or antipyretic substances,their use and pharmaceutical formulations containing them

GB9325445D0
(en)

1993-12-13
1994-02-16
Cortecs Ltd
Pharmaceutical formulations

US5763422A
(en)

*

1995-01-27
1998-06-09
Board Of Regents, The University Of Texas System
Methods of enhancing the therapeutic activity of NSAIDS and compositions of zwitterionic phospholipids useful therein

US5955451A
(en)

*

1995-05-12
1999-09-21
The University Of Texas System Board Of Regents
Methods of enhancing the therapeutic activity of NSAIDS and compositions of zwitterionic phospholipids useful therein

AUPN766496A0
(en)

*

1996-01-22
1996-02-15
University Of New England, The
Method and composition for the potentiation of anti-inflammatory drugs

AU2003201569B2
(en)

*

2002-01-21
2008-09-11
Vasogen Ireland Limited
Pharmaceutically acceptable phosphate-glycerol carrying bodies

AU2002346284A1
(en)

*

2002-04-26
2003-11-10
Rudolf Perl
Pharmaceutical compositions of phospholipid derivatives

AU2004257375A1
(en)

*

2003-07-21
2005-01-27
Vasogen Ireland Limited
Liposomes containing phosphate glycerol groups for treating acute inflammatory condition

Citations (3)

* Cited by examiner, † Cited by third party

Publication number
Priority date
Publication date
Assignee
Title

AU5391679A
(en)

*

1978-12-27
1980-07-03

A. Nattermann & Cie Gmbh

Pharmaceutical composition

AU8432282A
(en)

*

1981-06-01
1982-12-09

Pfizer Inc.

Crystalline benzothiazine dioxide salts

AU8432582A
(en)

*

1981-06-01
1983-06-02

Pfizer Inc.

Water-soluble benzothiazine dioxide salts

Family Cites Families (11)

* Cited by examiner, † Cited by third party

Publication number
Priority date
Publication date
Assignee
Title

US3787324A
(en)

*

1971-03-01
1974-01-22
Warner Lambert Co
4-hydroxy-3-(3-isoxazolocarbamyl)-2h-1,2-benzothiazine 1,dioxides and process for their production

FR2343481A1
(en)

*

1976-03-11
1977-10-07
Gerlich Norbert
Preventing damage to and repairing biomembranes – by adding lipid mixtures contg. phosphatidyl-choline,-serine-and-ethanolamine, and unsaturated fatty acids

AU518216B2
(en)

*

1977-09-06
1981-09-17
Hafslund Nycomed Pharma Aktiengesellschaft
Thienothiazine derivatives

JPS54117034A
(en)

*

1978-02-28
1979-09-11
Nippon Shoji Kk
Treating agent for consciousness and perception motion disorder

DE2856333C2
(en)

*

1978-12-27
1983-09-22
A. Nattermann & Cie GmbH, 5000 Köln

Oral medicines with anti-inflammatory effects

DE2914788A1
(en)

*

1979-04-11
1980-10-16
Nattermann A & Cie

PARENTERAL APPLICABLE, STABLE DRUG SOLUTIONS WITH ANTI-INFLAMMATORY EFFECT

DE3047011A1
(en)

*

1980-12-13
1982-07-22
A. Nattermann & Cie GmbH, 5000 Köln

METHOD FOR SEPARATING OIL AND / OR PHOSPHATIDYLETHANOLAMINE FROM THESE ALCOHOL-SOLUBLE PHOSPHATIDYLCHOLINE PRODUCTS CONTAINING IT

DE3047048A1
(en)

*

1980-12-13
1982-07-29
A. Nattermann & Cie GmbH, 5000 Köln

METHOD FOR SEPARATING OIL AND / OR PHOSPHATIDYLETHANOLAMINE FROM THESE ALCOHOL-SOLUBLE PHOSPHATIDYLCHOLINE PRODUCTS CONTAINING IT

DE3047012A1
(en)

*

1980-12-13
1982-07-22
A. Nattermann & Cie GmbH, 5000 Köln

METHOD FOR SEPARATING ACYLATED PHOSPHOLIPID FROM THESE CONTAINING PHOSPHATIDYLCHOLINE PRODUCTS

US4434163A
(en)

*

1981-06-01
1984-02-28
Pfizer Inc.
Water-soluble benzothiazine dioxide salts

DE3217315C2
(en)

*

1982-05-08
1986-05-22
Gödecke AG, 1000 Berlin

Medicinal preparations containing oxicam derivatives

1983

1983-12-22
DE
DE3346526A
patent/DE3346526C2/en
not_active
Expired

1984

1984-12-06
NO
NO844889A
patent/NO166569C/en
unknown

1984-12-10
PT
PT79649A
patent/PT79649B/en
not_active
IP Right Cessation

1984-12-12
CA
CA000469960A
patent/CA1234049A/en
not_active
Expired

1984-12-13
AT
AT84115358T
patent/ATE40793T1/en
not_active
IP Right Cessation

1984-12-13
DE
DE8484115358T
patent/DE3476734D1/en
not_active
Expired

1984-12-13
EP
EP84115358A
patent/EP0147735B1/en
not_active
Expired

1984-12-14
AU
AU36685/84A
patent/AU566974B2/en
not_active
Ceased

1984-12-14
IN
IN941/DEL/84A
patent/IN162327B/en
unknown

1984-12-18
IL
IL73849A
patent/IL73849A/en
unknown

1984-12-19
FI
FI845019A
patent/FI83287C/en
not_active
IP Right Cessation

1984-12-20
DD
DD84271295A
patent/DD233076A5/en
not_active
IP Right Cessation

1984-12-20
GR
GR82545A
patent/GR82545B/en
unknown

1984-12-20
PH
PH31618A
patent/PH21823A/en
unknown

1984-12-20
NZ
NZ210648A
patent/NZ210648A/en
unknown

1984-12-21
HU
HU844806A
patent/HU193729B/en
unknown

1984-12-21
OA
OA58484A
patent/OA07907A/en
unknown

1984-12-21
ZA
ZA849976A
patent/ZA849976B/en
unknown

1984-12-21
US
US06/685,152
patent/US4687766A/en
not_active
Expired – Lifetime

1984-12-21
DK
DK619484A
patent/DK619484A/en
not_active
Application Discontinuation

1984-12-21
ES
ES538982A
patent/ES8707111A1/en
not_active
Expired

1984-12-21
KR
KR1019840008219A
patent/KR920003602B1/en
not_active
IP Right Cessation

1984-12-21
MX
MX8252A
patent/MX159874A/en
unknown

1984-12-22
JP
JP59269684A
patent/JPS60169420A/en
active
Granted

1984-12-22
EG
EG796/84A
patent/EG17137A/en
active

Patent Citations (3)

* Cited by examiner, † Cited by third party

Publication number
Priority date
Publication date
Assignee
Title

AU5391679A
(en)

*

1978-12-27
1980-07-03
A. Nattermann & Cie Gmbh
Pharmaceutical composition

AU8432282A
(en)

*

1981-06-01
1982-12-09
Pfizer Inc.
Crystalline benzothiazine dioxide salts

AU8432582A
(en)

*

1981-06-01
1983-06-02
Pfizer Inc.
Water-soluble benzothiazine dioxide salts

Also Published As

Publication number
Publication date

DK619484D0
(en)

1984-12-21

DK619484A
(en)

1985-06-23

FI83287B
(en)

1991-03-15

HU193729B
(en)

1987-11-30

FI83287C
(en)

1991-06-25

FI845019L
(en)

1985-06-23

CA1234049A
(en)

1988-03-15

EG17137A
(en)

1992-12-30

US4687766A
(en)

1987-08-18

NZ210648A
(en)

1988-04-29

GR82545B
(en)

1985-04-24

IL73849A
(en)

1988-07-31

HUT35958A
(en)

1985-08-28

IL73849A0
(en)

1985-03-31

AU3668584A
(en)

1985-06-27

OA07907A
(en)

1986-11-20

NO166569C
(en)

1991-08-14

DE3476734D1
(en)

1989-03-23

IN162327B
(en)

1988-04-30

NO844889L
(en)

1985-06-24

FI845019A0
(en)

1984-12-19

KR850004395A
(en)

1985-07-15

JPH0112729B2
(en)

1989-03-02

PT79649B
(en)

1986-10-21

JPS60169420A
(en)

1985-09-02

EP0147735A3
(en)

1985-11-27

NO166569B
(en)

1991-05-06

DD233076A5
(en)

1986-02-19

EP0147735A2
(en)

1985-07-10

KR920003602B1
(en)

1992-05-04

EP0147735B1
(en)

1989-02-15

ES8707111A1
(en)

1987-07-16

DE3346526A1
(en)

1985-07-04

DE3346526C2
(en)

1986-12-11

MX159874A
(en)

1989-09-25

ATE40793T1
(en)

1989-03-15

PT79649A
(en)

1985-06-03

ES538982A0
(en)

1987-07-16

ZA849976B
(en)

1985-08-28

PH21823A
(en)

1988-03-04

Similar Documents

Publication
Publication Date
Title

FR2416012A1
(en)

1979-08-31

DERIVATIVES OF IMIDAZOLE AND MEDICINAL PRODUCTS CONTAINING THESE SUBSTANCES

PH27416A
(en)

1993-06-21

Stabilized medicine formulations

HUT38256A
(en)

1986-05-28

Process for producing combined pharmaceutical compositions containing xantine derivatives and o-acetyl-salicylic acid or pharmaceutically acceptables salts

ES2093440T3
(en)

1996-12-16

DERIVATIVES IN THE SERIES OF VITAMIN D WITH MODIFICATIONS IN POSITION 20, PROCEDURE FOR ITS PREPARATION, INTERMEDIATE PRODUCTS FOR THIS PROCEDURE, PHARMACEUTICAL PREPARATIONS CONTAINING THESE DERIVATIVES AS WELL AS THEIR USE FOR THE PREPARATION OF MEDICINES.

DE3377063D1
(en)

1988-07-21

Benzisoselenazolones, process for their preparation and pharmaceutical compositions containing them

AU566974B2
(en)

1987-11-05

Pharmaceutical preparations containing a phospholipidan an oxicam derivative

DE3468021D1
(en)

1988-01-21

Imidazol-2-yl mercapto alkanoic acids, process for producing the same and pharmaceutical preparations containing the same

ZA879280B
(en)

1989-08-30

Basically substituted phenylacetonitriles,their preparation and drugs containing these compounds

JPS6438086A
(en)

1989-02-08

Mevalonic acid derivative and manufacture

DE3269241D1
(en)

1986-03-27

Triazoloquinazolines, process for their preparation and pharmaceutical compositions containing them

ZA826453B
(en)

1983-08-31

Tricyclic thiazolyloxamic acids and their derivatives,their preparation,and therapeutic agents containing these compounds

DE3371515D1
(en)

1987-06-19

Cycloalkyl derivatives of benzisoselenazolones, process for their preparation and pharmaceutical compositions containing them

IL88222A0
(en)

1989-06-30

Medicaments comprising 2-pyrimidinyl-1-piperazine derivatives

ZA81927B
(en)

1982-03-31

Phenylpiperazine derivatives of 1,3,4-oxadiazolyphenols their preparation and therapeutic agents containing these compounds

ZA903352B
(en)

1991-02-27

Pharmaceutical composition for the treatment of protozoal diseases particularly of trypanosomiasis comprosing d-carnitine or an acyl derivative of d-carnitine

IT7945204D0
(en)

1979-03-05

PHARMACEUTICAL COMPOSITION FOR THE THERAPY OF MALE STERILITY

IT1095015B
(en)

1985-08-10

FURANIC DERIVATIVE FOR USE WHICH PHARMACEUTICAL PRODUCT PARTICULARLY FOR THE TREATMENT OF RHEUMATIC DISEASES AND METHOD FOR ITS PREPARATION

Download PDF in English

None